herenciageneticayenfermedad: Researchers find a class of drug that could be promising treatment for uveitis

viernes, 9 de noviembre de 2018

Researchers find a class of drug that could be promising treatment for uveitis

	November 9, 2018
	Pharmacy / Pharmacology
	The latest pharmacy / pharmacology news from News Medical

Monitor the Storage Conditions of Critical and High-Value Products

Measure temperature and other physical parameters using a cloud-based solution that allows access to historical data from any web browser. Alarms can be delivered by email, SMS, or voice synthesized phone call.

Read Full Article Here

Free pharma webinar “Supporting users in the evaluation of analysis curves”

This webinar illustrates how the powerful software solutions from NETZSCH make your everyday analytical work easier.

Learn More

Vibration Monitoring in Manufacturers of Pharmaceuticals

Accurate data capture is critical as part of a predictive maintenance plan in pharmaceutical manufacturing. Hansford Sensor’s believe that modern vibration monitoring techniques and technology can maximize performance.

UA pharmacology professors aim to avoid opioid analgesic tolerance

For thousands of Americans, opioids no longer relieve pain -- they cause pain. Known as "opioid tolerance," patients eventually become desensitized to opioids and more sensitive to pain after years of using the pain relievers.

	High-throughput Screening Using Small Molecule Libraries Small molecule libraries are often used in drug discovery to find molecules with the greatest activity or inhibitory potential against a particular target.

	Researchers find a class of drug that could be promising treatment for uveitis Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

	New discovery may unlock development of next-generation sleeping pill Insomnia is one of the major sleep problems with an estimated prevalence of 10% to 15% in the general population and 30% to 60% in the older population. Moreover, insomnia frequently co-occurs with a wide range of psychiatric disorders, including depression and anorexia.

	New drug discovery will increase safety of canine sedation and anesthesia A drug discovery made at the University of Helsinki's Faculty of Veterinary Medicine will increase the safety of animal sedation and anesthesia. Vatinoxan, the pharmacological molecule discovered in the study, reduced the adverse effects of other drugs on the cardiovascular system of canine patients.